378 related articles for article (PubMed ID: 33910214)
1. Current Approaches and Future Directions for the Treatment of mTORopathies.
Karalis V; Bateup HS
Dev Neurosci; 2021; 43(3-4):143-158. PubMed ID: 33910214
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency.
Chen CJ; Sgritta M; Mays J; Zhou H; Lucero R; Park J; Wang IC; Park JH; Kaipparettu BA; Stoica L; Jafar-Nejad P; Rigo F; Chin J; Noebels JL; Costa-Mattioli M
Nat Med; 2019 Nov; 25(11):1684-1690. PubMed ID: 31636454
[TBL] [Abstract][Full Text] [Related]
3. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
[TBL] [Abstract][Full Text] [Related]
4. Raptor downregulation rescues neuronal phenotypes in mouse models of Tuberous Sclerosis Complex.
Karalis V; Caval-Holme F; Bateup HS
Nat Commun; 2022 Aug; 13(1):4665. PubMed ID: 35945201
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic Target of Rapamycin Signaling Activation Antagonizes Autophagy To Facilitate Zika Virus Replication.
Sahoo BR; Pattnaik A; Annamalai AS; Franco R; Pattnaik AK
J Virol; 2020 Oct; 94(22):. PubMed ID: 32878890
[TBL] [Abstract][Full Text] [Related]
6. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
[TBL] [Abstract][Full Text] [Related]
7. Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma.
Jhanwar-Uniyal M; Dominguez JF; Mohan AL; Tobias ME; Gandhi CD
Adv Biol Regul; 2022 Jan; 83():100854. PubMed ID: 34996736
[TBL] [Abstract][Full Text] [Related]
8. Using tuberous sclerosis complex to understand the impact of MTORC1 signaling on mitochondrial dynamics and mitophagy in neurons.
Ebrahimi-Fakhari D; Saffari A; Wahlster L; Sahin M
Autophagy; 2017 Apr; 13(4):754-756. PubMed ID: 28121223
[TBL] [Abstract][Full Text] [Related]
9. Synergistic hyperactivation of both mTORC1 and mTORC2 underlies the neural abnormalities of PTEN-deficient human neurons and cortical organoids.
Dhaliwal NK; Weng OY; Dong X; Bhattacharya A; Ahmed M; Nishimura H; Choi WWY; Aggarwal A; Luikart BW; Shu Q; Li X; Wilson MD; Moffat J; Wang LY; Muffat J; Li Y
Cell Rep; 2024 May; 43(5):114173. PubMed ID: 38700984
[TBL] [Abstract][Full Text] [Related]
10. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.
Yoon MS
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077002
[TBL] [Abstract][Full Text] [Related]
11. Differential roles and activation of mammalian target of rapamycin complexes 1 and 2 during cell migration in prostate cancer cells.
Venugopal SV; Caggia S; Gambrell-Sanders D; Khan SA
Prostate; 2020 Apr; 80(5):412-423. PubMed ID: 31995655
[TBL] [Abstract][Full Text] [Related]
12. Epilepsy in the mTORopathies: opportunities for precision medicine.
Moloney PB; Cavalleri GL; Delanty N
Brain Commun; 2021; 3(4):fcab222. PubMed ID: 34632383
[TBL] [Abstract][Full Text] [Related]
13. The complex network of mTOR signalling in the heart.
Sciarretta S; Forte M; Frati G; Sadoshima J
Cardiovasc Res; 2022 Jan; 118(2):424-439. PubMed ID: 33512477
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin and mTORC2 inhibition synergistically reduce contraction-stimulated muscle protein synthesis.
Ogasawara R; Knudsen JR; Li J; Ato S; Jensen TE
J Physiol; 2020 Dec; 598(23):5453-5466. PubMed ID: 32893874
[TBL] [Abstract][Full Text] [Related]
15. Regulation and metabolic functions of mTORC1 and mTORC2.
Szwed A; Kim E; Jacinto E
Physiol Rev; 2021 Jul; 101(3):1371-1426. PubMed ID: 33599151
[TBL] [Abstract][Full Text] [Related]
16. mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells.
Zheng B; Wang J; Tang L; Shi J; Zhu D
Int J Dev Biol; 2017; 61(1-2):65-72. PubMed ID: 28287249
[TBL] [Abstract][Full Text] [Related]
17. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
[TBL] [Abstract][Full Text] [Related]
18. Selective interference of mTORC1/RAPTOR protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism with Akt and autophagy induction.
Ito M; Yurube T; Kakutani K; Maeno K; Takada T; Terashima Y; Kakiuchi Y; Takeoka Y; Miyazaki S; Kuroda R; Nishida K
Osteoarthritis Cartilage; 2017 Dec; 25(12):2134-2146. PubMed ID: 28888905
[TBL] [Abstract][Full Text] [Related]
19. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells.
Misra UK; Pizzo SV
PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152
[TBL] [Abstract][Full Text] [Related]
20. mTORC2 Loss in Oligodendrocyte Progenitor Cells Results in Regional Hypomyelination in the Central Nervous System.
Dahl KD; Almeida AR; Hathaway HA; Bourne J; Brown TL; Finseth LT; Wood TL; Macklin WB
J Neurosci; 2023 Jan; 43(4):540-558. PubMed ID: 36460463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]